Paper41314788
Decoding HBV-specific adaptive immunity: from natural clearance to cure.
Thimme R and 3 others. Gut, 2026. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Decoding HBV-specific adaptive immunity: from natural clearance to cure. Papers, record 41314788. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41314788
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adaptive Immunity | Major topic |
| Hepatitis B, Chronic | Major topic |
| Hepatitis B virus | Major topic |
| Humans | |
| Hepatitis B Vaccines | |
| Animals | |
| Antiviral Agents | |
| T-Lymphocytes |
Source PubMed
References126
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30084841 | PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection. | J Clin Invest | 2018 | https://conductscience.org/library/papers/30084841 | PubMed |
| 2 | 28165481 | Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B. | Nat Med | 2017 | https://conductscience.org/library/papers/28165481 | PubMed |
| 3 | 33398179 | Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection. | Nat Immunol | 2021 | https://conductscience.org/library/papers/33398179 | PubMed |
| 4 | 28737510 | Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28737510 | PubMed |
| 5 | 26684441 | Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B. | Gastroenterology | 2016 | https://conductscience.org/library/papers/26684441 | PubMed |
| 6 | 28394272 | HBV DNA Integration: Molecular Mechanisms and Clinical Implications. | Viruses | 2017 | https://conductscience.org/library/papers/28394272 | PubMed |
| 7 | 34618559 | Ten millennia of hepatitis B virus evolution. | Science | 2021 | https://conductscience.org/library/papers/34618559 | PubMed |
| 8 | 27156385 | Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission. | Immunity | 2016 | https://conductscience.org/library/papers/27156385 | PubMed |
| 9 | 37368993 | Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-α in patients with chronic hepatitis B. | Hepatology | 2024 | https://conductscience.org/library/papers/37368993 | PubMed |
| 10 | 18695005 | Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. | J Exp Med | 2008 | https://conductscience.org/library/papers/18695005 | PubMed |
| 11 | 17039255 | Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. | J Clin Invest | 2006 | https://conductscience.org/library/papers/17039255 | PubMed |
| 12 | 16537621 | Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. | J Virol | 2006 | https://conductscience.org/library/papers/16537621 | PubMed |
| 13 | 30676822 | CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. | Annu Rev Immunol | 2019 | https://conductscience.org/library/papers/30676822 | PubMed |
| 14 | 9727065 | Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9727065 | PubMed |
| 15 | 30930022 | Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis. | Gastroenterology | 2019 | https://conductscience.org/library/papers/30930022 | PubMed |
| 16 | 40043858 | The Impact of Hepatitis B Surface Antigen Reduction via Small Interfering RNA Treatment on Natural and Vaccine (BRII-179)-Induced Hepatitis B Virus-Specific Humoral and Cellular Immune Responses. | Gastroenterology | 2025 | https://conductscience.org/library/papers/40043858 | PubMed |
| 17 | 8697635 | Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection. | Clin Exp Immunol | 1996 | https://conductscience.org/library/papers/8697635 | PubMed |
| 18 | 38423478 | Single-cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity. | J Hepatol | 2024 | https://conductscience.org/library/papers/38423478 | PubMed |
| 19 | 11050064 | Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. | Hepatology | 2000 | https://conductscience.org/library/papers/11050064 | PubMed |
| 20 | 36697826 | Tissue CD14+CD8+ T cells reprogrammed by myeloid cells and modulated by LPS. | Nature | 2023 | https://conductscience.org/library/papers/36697826 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42789423 | Sequential combination of anti-PD-1 antibody and PEG-IFNα in chronic hepatitis B patients: correlates of HBsAg loss with enhanced T-cell responses. | Emerg Microbes Infect | 2026 | https://conductscience.org/library/papers/42789423 | PubMed |
| 41912891 | T cell adaptation in chronic infections and tumors. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/41912891 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41314788
GET https://conductscience.org/api/papers/v1/41314788/references?page=2